Retinal layer thickness is decreased in glaucomatous eyes


The thickness of several different layers of the retina is reduced in eyes with glaucoma

"With this in mind, our research team conducted a study focusing on the role of the macula in glaucoma, analysing the configuration of the retinal layers to isolate any pathologic thinning in glaucomatous eyes and to identify the topographic distribution of any such thinning," he said. The results of the study were presented at the most recent annual congress of the European Association for Vision and Eye Research (EVER), which was held in Nice, France.

For the purposes of this study, the team were specifically interested in the retinal nerve fibre layer (RNFL), the retinal ganglion cell plus inner plexiform layer (RGIPL) and the retina as a whole. The central 5° area of the macula was then also divided into 65 segments for further evaluation.

"The maculae of healthy subjects (n = 112; age range: 20–76 years) were scanned with the Cirrus (Carl Zeiss Meditec, Jena, Germany) high definition optical coherence tomography (HD-OCT) instrument, and the 512 x 128 three-dimensional scans were then subjected to quantitative analysis using Matlab R2009b software (The Mathworks Inc., Cambridge, UK), which was developed by our research team," Dr Holzer added. Matlab R2009b locates and 'locks on' to the fovea to increase the accuracy of the positioning of the HD-OCT, as focusing is difficult for glaucoma patients; once the eye is in the correct position, the software automatically detects retinal layers without any manual correction required, which is unique.

He continued, "Using the thickness data we gathered from these scans of healthy eyes, we built colour-coded thickness maps and a normative database (taking into account the effects of age), against which we compared thickness data gathered from subjects with glaucoma of varying stages (n = 25; age range: 42–79 years)." Patients with pre-existing retinal neuropathy were excluded from the study.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.